Mitsubishi has officially entered the humanoid robot market, announcing a production target of 1,000 units per month. This marks a significant transition from prototype development to industrial-scale manufacturing, positioning the company alongside key players in the rapidly evolving robotics sector.
The planned production volume signals strong confidence in commercial demand for bipedal robots across logistics, manufacturing, and service industries. Unlike consumer drones or simpler automated systems, these humanoid platforms require advanced power architectures to support complex locomotion, sensing, and computing loads.
This scale-up creates substantial new demand for high-performance battery systems. Humanoid robots operate continuously in dynamic environments, necessitating power sources that deliver high energy density, extended cycle life, and robust thermal management. Safety systems are also critical, given the proximity of these machines to human workers in shared spaces.
For B2B suppliers, this means a growing market for specialized lithium-ion and solid-state battery packs that can withstand frequent charge-discharge cycles while maintaining stable output under varying loads. The move is expected to accelerate the development of standardized battery module form factors for robotics, similar to what the automotive industry achieved with EV platforms.
Industry analysts note that Mitsubishi's entry could spur innovation in modular battery designs, enabling easier maintenance and lower total cost of ownership for fleet operators. This trend aligns with broader supply chain shifts toward localized battery production to reduce logistics risks and meet regional regulatory standards.
Source: Electrek, August 7, 2026. The original report can be found here.
Mass-production humanoid robots need specialized battery systems. We focus on custom battery solutions for robotics, optimizing design and BMS for rapid, low-volume production. Our online tool https://tool.liion-batt.com helps select compatible cells and shorten R&D cycles.